Henrike Jacoba Jacoba Brands

Mrs. Henrike Jacoba Jacoba Brands


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2023 in Cancers
Verified
Journal Article
Open access
PDF file
HBHenrike Jacoba Jacoba Brands
Henrike Jacoba Jacoba Brands
BDBrigit Van Dijk
Brigit Van Dijk
RBRichard Brohet
Richard Brohet
HWHenderik L. van Westreenen
Henderik L. van Westreenen
Jan Willem B. De GrootJan Willem B. De Groot
Jan Willem B. De Groot
WCWouter H de Vos tot Nederveen Cappel
Wouter H de Vos tot Nederveen Cappel
If Colorectal cancer (CRC) is detected and treated early, the survival rate is high. This is one of the reasons that population-based screening programs for the early detection of CRC using the faecal immunochemical test (FIT) started worldwide. These programs compete with regular colonoscopy programs and increase the waiting time for symptomatic patients. However, the literature has shown that the correlation between intestinal complaints and the gain of colonoscopy is poor. The aim of this study is to assess the diagnostic utility of symptoms for the yield (CRC) of colonoscopy and to compare this with the diagnostic utility of FIT when offered to symptomatic patients. Methods: We performed a systematic review search for CRC as an outcome of colonoscopy in referred symptomatic patients and separately for CRC as an outcome in symptomatic patients with a positive FIT. We searched systematically for clinical trials or observational studies in databases, followed by hand-searching of reference lists. We used random Meta-Disc to evaluate the diagnostic performance, using the exploration of heterogeneity with a variety of test statistics and by computing the pooled estimates. Results: We included 35 studies, with almost 5 million symptomatic patients. In addition, we included nine prospective studies with a positive FIT in symptomatic patients, with more than 5000 patients. Significant heterogeneity was found for every symptom and the outcome of colonoscopy in the effect size of sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio. In a random effect model, the pooled sensitivity of colonoscopy in symptomatic patients was very low (25%). However, the pooled sensitivity in symptomatic patients with a positive FIT was 83% and the pooled specificity 77%. A total of 75 symptomatic patients (1.4%) had a false-negative FIT. Conclusion: Adding FIT in symptomatic patients seems useful for predicting CRC as an outcome of colonoscopy. FIT seems a potential tool for an improved triage of colonoscopy in symptomatic patients.

1 March 2018
Verified
Journal Article
Closed access
HBHenrike Jacoba Jacoba Brands
Henrike Jacoba Jacoba Brands
JLJ. Lupton
J. Lupton
MKM. van't Veer-ten Kate
M. van't Veer-ten Kate
WCW. H. de Vos Tot Nederveen Cappel
W. H. de Vos Tot Nederveen Cappel

1 March 2018
Verified
Journal Article
Closed access
HBHenrike Jacoba Jacoba Brands
Henrike Jacoba Jacoba Brands
SRS. Riemens
S. Riemens
JGJ. Starre-van der Gaal
J. Starre-van der Gaal
SLS. Lupton
S. Lupton